Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT02552459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02552459
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02552459. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery
Condition
Arteriovenous Malformation
Intervention (Drug)
Sufentanil
Intervention (Drug)
dexmedetomidine 1
Intervention (Drug)
dexmedetomidine 2
Intervention (Drug)
dexmedetomidine 3
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University (class: other)

Record details

Record id
cardio:ct-nct02552459
Content hash
956553d2b1651fb81b258292f5e26b43a9220647bce4c2e8ebb88c120e3aada5